Jpmorgan Chase & CO Avanos Medical, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 350,605 shares of AVNS stock, worth $3.75 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
350,605
Previous 201,634 73.88%
Holding current value
$3.75 Million
Previous $3.21 Million 56.51%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
BUY
$13.95 - $17.45 $2.08 Million - $2.6 Million
148,971 Added 73.88%
350,605 $5.02 Million
Q4 2024

Feb 12, 2025
BUY
$15.58 - $23.61 $2.06 Million - $3.12 Million
132,063 Added 189.82%
201,634 $3.21 Million
Q3 2024

Dec 26, 2024
BUY
$19.21 - $24.69 $85,907 - $110,413
4,472 Added 6.87%
69,571 $1.67 Million
Q3 2024

Nov 08, 2024
BUY
$19.21 - $24.69 $85,907 - $110,413
4,472 Added 6.87%
69,571 $1.67 Million
Q2 2024

Dec 26, 2024
SELL
$17.85 - $20.42 $79,825 - $91,318
-4,472 Reduced 6.43%
65,099 $1.3 Million
Q2 2024

Aug 12, 2024
SELL
$17.85 - $20.42 $1.11 Million - $1.27 Million
-62,019 Reduced 48.79%
65,099 $1.3 Million
Q1 2024

Dec 26, 2024
BUY
$17.97 - $22.68 $1.03 Million - $1.31 Million
57,547 Added 82.72%
127,118 $2.53 Million
Q1 2024

May 10, 2024
SELL
$17.97 - $22.68 $1.37 Million - $1.73 Million
-76,110 Reduced 37.45%
127,118 $2.53 Million
Q4 2023

Dec 26, 2024
BUY
$17.64 - $22.99 $2.36 Million - $3.07 Million
133,657 Added 192.12%
203,228 $4.56 Million
Q4 2023

Feb 12, 2024
SELL
$17.64 - $22.99 $781,646 - $1.02 Million
-44,311 Reduced 17.9%
203,228 $4.56 Million
Q3 2023

Nov 14, 2023
BUY
$19.93 - $26.31 $2.62 Million - $3.45 Million
131,222 Added 112.81%
247,539 $5.01 Million
Q2 2023

Aug 11, 2023
BUY
$22.53 - $30.98 $304,087 - $418,137
13,497 Added 13.13%
116,317 $2.97 Million
Q1 2023

May 18, 2023
BUY
$26.92 - $31.75 $1.57 Million - $1.85 Million
58,240 Added 130.64%
102,820 $3.06 Million
Q1 2023

May 11, 2023
SELL
$26.92 - $31.75 $1.31 Million - $1.55 Million
-48,759 Reduced 52.24%
44,580 $1.33 Million
Q4 2022

Feb 13, 2023
SELL
$19.88 - $27.37 $14,393 - $19,815
-724 Reduced 0.77%
93,339 $2.53 Million
Q3 2022

Nov 14, 2022
SELL
$21.56 - $29.59 $3.47 Million - $4.77 Million
-161,086 Reduced 63.13%
94,063 $2.05 Million
Q2 2022

Aug 11, 2022
BUY
$24.87 - $34.68 $4.37 Million - $6.1 Million
175,806 Added 221.58%
255,149 $6.98 Million
Q1 2022

May 11, 2022
BUY
$28.87 - $35.77 $843,465 - $1.05 Million
29,216 Added 58.28%
79,343 $2.66 Million
Q4 2021

Feb 10, 2022
BUY
$29.25 - $36.02 $72,247 - $88,969
2,470 Added 5.18%
50,127 $1.74 Million
Q3 2021

Nov 12, 2021
BUY
$31.2 - $38.5 $1.49 Million - $1.83 Million
47,657 New
47,657 $1.49 Million

Others Institutions Holding AVNS

# of Institutions
308
Shares Held
44.4M
Call Options Held
0
Put Options Held
21.8K
View Full List

About AVANOS MEDICAL, INC.

AVNS Quotes by TradingView
  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $497M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email